Having trouble viewing this email? Click here.
 
A SPECIAL
ANNOUNCEMENT FROM:
   
 

Introducing

ACQUITY UPLC BEH125 SEC, 1.7 µm Columns

The new ACQUITY UPLC BEH125 SEC columns are specifically developed and optimized for biotherapeutic aggregate analyses of proteins ranging from 1,000 to 80,000 daltons.

  • QC tested with relevant proteins, ensuring unmatched batch-to-batch consistency and increased confidence in validated methods.
  • Determines accurate aggregate levels in less time compared to many traditional HPLC-based, Size Exclusion Chromatography (SEC) methods.
  • ACQUITY UPLC BEH200 SEC Columns are also available.

Click Here to Enlarge Chromatogram

Click Here to Enlarge Chromatogram

Waters Global Offices

Waters Corporation, 34 Maple Street, Milford, MA, USA 01757
www.waters.com

©2012 Waters Corporation. Waters, ACQUITY UPLC and The Science of What's Possible are trademarks of Waters Corporation.

Shop NowLearn more

 


BioPharm International is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ 08830.
This is an advertisement sent on behalf of this advertiser.

 

 

Brochure whitepaper Application Notes Downloads